Sitagliptin phosphate monohydrate / simvastatin
Key facts
| Active substance |
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/172/2009
|
| PIP number |
Sitagliptin phosphate monohydrate / simvastatin
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|